×
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
NASDAQ:TXMD

TherapeuticsMD Short Interest Ratio and Short Volume

$2.15
-0.41 (-16.02%)
(As of 05/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.05
$2.40
50-Day Range
$2.15
$21.78
52-Week Range
$2.05
$69.50
Volume
1.52 million shs
Average Volume
478,332 shs
Market Capitalization
$18.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.09

TherapeuticsMD (NASDAQ:TXMD) Short Interest Data

Current Short Volume
757,300 shares
Previous Short Volume
31,900,000 shares
Change Vs. Previous Month
-97.63%
Dollar Volume Sold Short
$7.64 million
Short Interest Ratio / Days to Cover
4.3
Last Record Date
April, 30 2022
Outstanding Shares
8,669,000 shares
Float Size
7,610,000 shares
Short Percent of Float
9.95%
Today's Trading Volume
1,517,693 shares
Average Trading Volume
478,332 shares
Today's Volume Vs. Average
217.29%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling TherapeuticsMD ?

Sign up to receive the latest short interest report for TherapeuticsMD and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time


TherapeuticsMD (NASDAQ:TXMD) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2022757,300 shares $7.64 million -97.6%10.0%4.3 $10.09
4/15/202231,900,000 shares $9.25 million +2.8%8.4%4.5 $0.29
3/31/202231,030,000 shares $11.79 million -2.6%8.2%4.7 $0.38
3/15/202231,870,000 shares $10.37 million +28.6%N/A4.1 $0.33
2/28/202224,790,000 shares $5.93 million -2.4%N/A3.3 $0.24
2/15/202225,410,000 shares $6.68 million +11.6%N/A3.8 $0.26
1/31/202222,760,000 shares $6.92 million -10.2%N/A3.4 $0.30
1/15/202225,350,000 shares $8.75 million +35.2%N/A4.1 $0.35
12/31/202118,750,000 shares $6.67 million -29.4%N/A3.2 $0.36
12/15/202126,550,000 shares $10.78 million -20.0%N/A5.7 $0.41
11/30/202133,180,000 shares $16.42 million +9.9%N/A6.9 $0.50
11/15/202130,180,000 shares $18.50 million +3.6%N/A7 $0.61
10/29/202129,130,000 shares $21.21 million +2.5%N/A6.3 $0.73
10/15/202128,430,000 shares $20.49 million -1.6%N/A5.7 $0.72
9/30/202128,890,000 shares $21.42 million +0.7%N/A5.6 $0.74
9/15/202128,680,000 shares $20.74 million +24.4%N/A4.8 $0.72
8/31/202123,060,000 shares $18.33 million +2.1%5.9%4.1 $0.80
8/13/202122,580,000 shares $19.45 million -30.2%N/A4 $0.86
7/30/202132,340,000 shares $32.34 million -4.9%N/A5.9 $1.00
7/15/202134,000,000 shares $35.02 million -39.3%9.3%5.4 $1.03
6/30/202156,000,000 shares $66.64 million -1.1%15.3%8 $1.19
6/15/202156,620,000 shares $71.34 million -5.1%15.4%8 $1.26
5/28/202159,670,000 shares $72.20 million -3.8%16.3%7 $1.21
5/14/202162,040,000 shares $65.76 million -4.1%N/A5.9 $1.06
4/30/202164,690,000 shares $72.45 million +0.0%N/A4.4 $1.12













TherapeuticsMD (NASDAQ:TXMD) Short Interest Frequently Asked Questions

What is TherapeuticsMD's current short interest?

Short interest is the volume of TherapeuticsMD shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 757,300 shares of TXMD short. 9.95% of TherapeuticsMD's shares are currently sold short. Learn More on TherapeuticsMD's current short interest.

What is a good short interest ratio for TherapeuticsMD?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TherapeuticsMD currently has a short interest ratio of 4.0. Learn More on TherapeuticsMD's short interest ratio.

Which institutional investors are shorting TherapeuticsMD?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of TherapeuticsMD: Group One Trading L.P., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for TherapeuticsMD?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.95% of TherapeuticsMD's floating shares are currently sold short.

Is TherapeuticsMD's short interest increasing or decreasing?

TherapeuticsMD saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 757,300 shares, a decline of 97.6% from the previous total of 31,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TherapeuticsMD's float size?

TherapeuticsMD currently has issued a total of 8,669,000 shares. Some of TherapeuticsMD's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TherapeuticsMD currently has a public float of 7,610,000 shares.

How does TherapeuticsMD's short interest compare to its competitors?

9.95% of TherapeuticsMD's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to TherapeuticsMD: Anebulo Pharmaceuticals, Inc. (0.02%), HCW Biologics Inc. (0.20%), Eyenovia, Inc. (1.61%), Galectin Therapeutics Inc. (5.64%), Annovis Bio, Inc. (3.07%), BriaCell Therapeutics Corp. (15.67%), Aeglea BioTherapeutics, Inc. (5.78%), Magenta Therapeutics, Inc. (3.62%), Merrimack Pharmaceuticals, Inc. (2.12%), and PLx Pharma Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Palo Alto Networks, Inc. ($4.31 billion), Charter Communications, Inc. ($3.24 billion), Lucid Group, Inc. ($2.25 billion), HP Inc. ($2.22 billion), GameStop Corp. ($1.69 billion), Carnival Co. & plc ($1.66 billion), Snap Inc. ($1.64 billion), Wayfair Inc. ($1.63 billion), Rivian Automotive, Inc. ($1.60 billion), and Upstart Holdings, Inc. ($1.53 billion). View all of the most shorted stocks.

What does it mean to sell short TherapeuticsMD stock?

Short selling TXMD is an investing strategy that aims to generate trading profit from TherapeuticsMD as its price is falling. TherapeuticsMD's stock is trading down $0.41 today. To short TherapeuticsMD stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that TherapeuticsMD will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TherapeuticsMD?

A short squeeze for TherapeuticsMD occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TXMD, which in turn drives the price of the stock up even further.

How often is TherapeuticsMD's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TXMD, twice per month. The most recent reporting period available is April, 30 2022.



This page was last updated on 5/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.